+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06851949

Clinical Evaluation of the Vsling Device for Ventricular Repair in Adults with Heart Failure and Reduced Ejection Fraction

Led by Cardiac Success · Updated on 2026-10-28

20

Participants Needed

5

Research Sites

226 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the Vsling device in patients with heart failure who have a reduced left ventricular ejection fraction and ventricular dilation. This prospective, multi-center, open-label clinical study aims to assess the feasibility, initial safety, and performance of the Vsling device as a treatment for this condition. The study is sponsored by Cardiac Success and is conducted as a phase 2 interventional trial. Participants will undergo implantation of the Vsling device, which is designed to repair the ventricle. The device is implanted via a catheter, and there is only one study group receiving this experimental intervention. The primary treatment period focuses on device implantation and monitoring. Throughout the study, participants will be closely monitored for device-related serious adverse events within 30 days after implantation. Assessments include echocardiographic evaluations, clinical status monitoring, and other safety observations. Participants will provide informed consent and be followed up for outcome measures and adverse events to evaluate device performance and safety over the course of the trial.

CONDITIONS

Brief Title

Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure

Research Team

T

Tami Abudi, +972

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here